254 related articles for article (PubMed ID: 33303630)
1. Structural basis for antigen recognition by methylated lysine-specific antibodies.
Ishii M; Nakakido M; Caaveiro JMM; Kuroda D; Okumura CJ; Maruyama T; Entzminger K; Tsumoto K
J Biol Chem; 2021; 296():100176. PubMed ID: 33303630
[TBL] [Abstract][Full Text] [Related]
2. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
[TBL] [Abstract][Full Text] [Related]
3. Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation.
Hattori T; Lai D; Dementieva IS; Montaño SP; Kurosawa K; Zheng Y; Akin LR; Świst-Rosowska KM; Grzybowski AT; Koide A; Krajewski K; Strahl BD; Kelleher NL; Ruthenburg AJ; Koide S
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2092-7. PubMed ID: 26862167
[TBL] [Abstract][Full Text] [Related]
4. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
[TBL] [Abstract][Full Text] [Related]
5. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
6. High affinity antigen recognition of the dual specific variants of herceptin is entropy-driven in spite of structural plasticity.
Bostrom J; Haber L; Koenig P; Kelley RF; Fuh G
PLoS One; 2011 Apr; 6(4):e17887. PubMed ID: 21526167
[TBL] [Abstract][Full Text] [Related]
7. Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico Insights.
Gray ER; Brookes JC; Caillat C; Turbé V; Webb BLJ; Granger LA; Miller BS; McCoy LE; El Khattabi M; Verrips CT; Weiss RA; Duffy DM; Weissenhorn W; McKendry RA
ACS Infect Dis; 2017 Jul; 3(7):479-491. PubMed ID: 28591513
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the antigen-binding fragment of a monoclonal antibody specific for the multidrug-resistance-linked ABC transporter human P-glycoprotein.
Esser L; Shukla S; Zhou F; Ambudkar SV; Xia D
Acta Crystallogr F Struct Biol Commun; 2016 Aug; 72(Pt 8):636-41. PubMed ID: 27487928
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for differential recognition of phosphohistidine-containing peptides by 1-pHis and 3-pHis monoclonal antibodies.
Kalagiri R; Stanfield RL; Meisenhelder J; La Clair JJ; Fuhs SR; Wilson IA; Hunter T
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33547238
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display.
Hong WW; Yen YH; Wu SC
Biochem Biophys Res Commun; 2007 Apr; 356(1):124-8. PubMed ID: 17350601
[TBL] [Abstract][Full Text] [Related]
12. G196 epitope tag system: a novel monoclonal antibody, G196, recognizes the small, soluble peptide DLVPR with high affinity.
Tatsumi K; Sakashita G; Nariai Y; Okazaki K; Kato H; Obayashi E; Yoshida H; Sugiyama K; Park SY; Sekine J; Urano T
Sci Rep; 2017 Mar; 7():43480. PubMed ID: 28266535
[TBL] [Abstract][Full Text] [Related]
13. Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation.
Chung J; Rader C; Popkov M; Hur YM; Kim HK; Lee YJ; Barbas CF
FASEB J; 2004 Feb; 18(2):361-3. PubMed ID: 14688205
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
[TBL] [Abstract][Full Text] [Related]
15. Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism.
Chi SW; Maeng CY; Kim SJ; Oh MS; Ryu CJ; Kim SJ; Han KH; Hong HJ; Ryu SE
Proc Natl Acad Sci U S A; 2007 May; 104(22):9230-5. PubMed ID: 17517649
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.
Adachi M; Kurihara Y; Nojima H; Takeda-Shitaka M; Kamiya K; Umeyama H
Protein Sci; 2003 Oct; 12(10):2125-31. PubMed ID: 14500870
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of potential sites for antibody engineering by fluctuation editing.
Yanaka S; Moriwaki Y; Tsumoto K; Sugase K
Sci Rep; 2017 Aug; 7(1):9597. PubMed ID: 28855581
[TBL] [Abstract][Full Text] [Related]
18. The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups.
Haji-Ghassemi O; Müller-Loennies S; Rodriguez T; Brade L; Grimmecke HD; Brade H; Evans SV
J Biol Chem; 2016 May; 291(19):10104-18. PubMed ID: 26933033
[TBL] [Abstract][Full Text] [Related]
19. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
20. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
